Refine
Has Fulltext
- yes (52)
Is part of the Bibliography
- yes (52)
Year of publication
Document Type
Language
- English (52)
Keywords
- Toxikologie (32)
- Adenosine receptors (8)
- Adenosinrezeptor (5)
- Adenylate cyclase (4)
- G proteins (4)
- Pharmakologie (4)
- signal transduction (3)
- A1 adenosine receptors (2)
- Adenosin (2)
- G-protein (2)
- N-formyl peptides (2)
- Pharmazie (2)
- Radioligand binding (2)
- adenosine receptors (2)
- mast cells (2)
- membrane skeleton (2)
- (Rat brain membrane) (1)
- A(2B) receptors (1)
- A1 (1)
- A1 Adenosine receptors (1)
- A<sub>2</sub> Adenosine receptor (1)
- A\(_{2A}\) adenosine receptor antagonist (1)
- Adenosine receptor (1)
- Adenosine receptor antagonists (1)
- Atria (1)
- Barbiturat (1)
- Barbiturates (1)
- Chemotactic receptors (1)
- Cyclic AMP (1)
- Dermatologie (1)
- GABA-receptor complex (1)
- Human platelets (1)
- Immunologie (1)
- Ischemia/reperfusion (1)
- K + -channels (1)
- LTB4 receptor (1)
- Leukocyte/endothelium interaction (1)
- Lung (1)
- Mastzelle (1)
- Microcirculation (1)
- Molekularpharmakologie (1)
- N1E 115 cells (1)
- Niere (1)
- Phosphodiesterase (1)
- Photoaffinity labelling (1)
- Radiation inactivation (1)
- Radioligand binding - 86Rb + -efflux (1)
- Radioligands (1)
- Radioligauds (1)
- Ratte (1)
- Species differences (1)
- Target size (1)
- Theophylline (1)
- Venerologie (1)
- Xanthines (1)
- [3H]PIA binding (1)
- actin (1)
- adenosine (1)
- adenosine 3',5'-cyclic monophosphate (1)
- adenylate cyclase (1)
- agonists (1)
- antagonists (1)
- anti-Parkinson agents (1)
- anti-inflammatory agents (1)
- atopic eczema (1)
- barbiturates (1)
- binding affinity (1)
- brain membranes (1)
- calcium (1)
- chalcone (1)
- chemotactic receptors (1)
- chemotaxis (1)
- classification (1)
- coated vesicles (1)
- coumarin (1)
- cytoskeleton (1)
- desensitization (1)
- docking (1)
- drug (1)
- formyl peptides (1)
- gastrointestinal cancer (1)
- hA<sub>3</sub>AR (1)
- histamine release (1)
- human A(3) (1)
- human lung (1)
- indolylpyrimidylpiperazines (1)
- international union (1)
- molecular modeling (1)
- neurodegenerative diseases (1)
- neutrophils (1)
- partial agonists (1)
- phosphoinositides (1)
- photoaffinity labelling (1)
- potent (1)
- protein-coupled receptors (1)
- psoriasis (1)
- purine derivatives (1)
- radioligand (1)
- rat brain membranes (1)
- receptor binding (1)
- receptor solubilization (1)
- receptor-G protein coupling (1)
- receptor-G protein coupling. (1)
- receptors (1)
- solubilization (1)
- subtypes (1)
- targets (1)
- triazolotriazine derivatives (1)
Institute
Barbiturates inhibit binding of radioligands to A 1(Ri) adenosine receptors of rat brain membranes. This inhibition is dose-dependent and stereospecific and occurs in the range of pharmacologically active concentrations. The displacement of radiolabelled A1antagonists by barbiturates is not modified by GTP, indicating that barbiturates might act as antagonists at this receptor. This action of barbiturates does not seem to be related to the binding of barbiturates to plasma membranes, as the latter process has different characteristics. Barbiturates also inhibit the binding of radioligands to solubilized A1receptors, and saturation and kinetic experiments suggest that this is due to a competitive antagonism. These results indicate that barbiturates interact with the recognition site of the A1adenosine receptor.
The actions of adenosine on histamine release of human lung fragments were investigated. Histamine release was stimulated either with the calcium ionophore A 23187 orwith concanavalin A. Adenosine and its analogue 5'-N-ethylcarboxamidoadenosine alone had no significant effect on basal release or on the release elicited by A 23187 or concanavalin A. However, in the presence of the adenosine receptor antagonist 8-[4-[[[[(2-aminoethyl)amino]-carbonyl] methyloxy]-phenyl]-1,3-dipropylaxanthine (XAC), which itself did not affect the release, adenosine increased the stimulated histamine release. On the other hand, in the presence of the nucleoside transport inhibitor S-(p-nitrobenzyl)-6-thioninosine (NBTI), adenosine caused a reduction in stimulated histamine release. NBTI itself caused a stimulation of release. Thus, a stimulatory effect of adenosine was seen in the presence ofXAC, whereas an inhibitory effect was unmasked by NBTI. From these data it is concluded that adenosine exerts two opposing effects on histamine release in the human lung which neutralize each other: it inhibits release via a si te antagonized by XAC, which presumably represents an A2 adenosine receptor, and it stimulates release via a mechanism that is blocked by NBTI, suggesting that adenosine needs to reach the interior of cells to exert this effect. The slight stimulatory effect of NBTI alone demonstrates that trapping intracellularly formed adenosine inside mast cells leads to sufficient concentrations of adenosine to stimulate histamine release. These findings suggest an important bimodal role of adenosine in regulating histamine release in the human lung.